Is direct-to-consumer (DTC) marketing by pharmaceutical companies flat-lining?
Not yet. But the outlook isn’t good. TNS estimated in 2008 that total US DTC advertising spending would be $4.7 billion that year, down from $5.2 billion in 2007.
Source: eMarketer, June 3, 2009
